Latest Breaking News On - Clinical trials program - Page 2 : comparemela.com

Families dismayed by FDA decision to delay decision on Alzheimer s drug

Families dismayed by FDA decision to delay decision on Alzheimer s drug
newsday.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from newsday.com Daily Mail and Mail on Sunday newspapers.

United statesMarc gordonLori maldavirEli lillyNikhil palekarGeorge gatesStony brook centerJournal of the american medical associationClinical trials programDrug administrationNorthwell health drMaria gatesClinical trialsAmerican medical associationZucker hillside hospitalProgram outreach

Dr Merchan on Key Data Supporting Pembrolizumab-Based Regimens in Advanced RCC

Jaime R. Merchán, MD, discusses the role of pembrolizumab plus axitinib or lenvatinib in previously untreated advanced renal cell carcinoma.

Jaimer merchDivision of medical oncologyDepartment of medicineClinical trials programUniversity of miami health systemSylvester comprehensive cancer centerClinical oncology research programMedical oncologyTrials programMiami health systemCancers symposiumAdvanced rcc

Cytokinetics Announces Positive Results From SEQUOIA-HCM, the Pivotal Phase 3 Clinical Trial of Aficamten in Patients With Obstructive Hypertrophic Cardiomyopathy -December 27, 2023 at 07:31 am EST

Statistically Significant and Clinically Meaningful Increasein Primary Efficacy Endpoint at 24 Weeks of Treatment; Improvement Consistent Across All Prespecified Subgroups Statistically Significant.

United statesFadyi malikDiane weiserMartin maronTufts university school of medicineExchange commissionUs food drug administrationGlobenewswire incCytokinetics incorporated nasdaqNational medical products administrationCytokinetics incorporatedCorporate communicationsResearch developmentSymphony healthClinical trials programHypertrophic cardiomyopathy center

New Interim, Real-World Data Provides Additional Insights on Hyperkalemia and Safety of Kerendia® (finerenone) for Patients with Chronic Kidney Disease Associated with Type 2 Diabetes

New Interim, Real-World Data Provides Additional Insights on Hyperkalemia and Safety of Kerendia® (finerenone) for Patients with Chronic Kidney Disease Associated with Type 2 Diabetes
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesRobert perkinsSemin nephrolNational institute of diabetesClinical trials programAmerican society of nephrologyYork heart associationAmerican kidney fundNational institutes of healthAmerican diabetes associationCenters for diseaseNational diabetes statisticsAmerican association of clinical endocrinologyBayer healthcare pharmaceuticals incAmerican societyKidney week

New Interim, Real-World Data Provides Additional Insights on Hyperkalemia and Safety of Kerendia® (finerenone) for Patients with Chronic Kidney Disease Associated with Type 2 Diabetes

New Interim, Real-World Data Provides Additional Insights on Hyperkalemia and Safety of Kerendia® (finerenone) for Patients with Chronic Kidney Disease Associated with Type 2 Diabetes
valdostadailytimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from valdostadailytimes.com Daily Mail and Mail on Sunday newspapers.

United statesSemin nephrolRobert perkinsNational diabetes statisticsAmerican association of clinical endocrinologyAmerican diabetes associationNational institute of diabetesCenters for diseaseNational institutes of healthAmerican kidney fundBayer healthcare pharmaceuticals incClinical trials programAmerican society of nephrologyAmerican societyKidney weekVice president